Zinc and copper: Pharmacological probes and endogenous modulators of neuronal excitability
- 1 September 2006
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 111 (3) , 567-583
- https://doi.org/10.1016/j.pharmthera.2005.11.004
Abstract
No abstract availableKeywords
This publication has 174 references indexed in Scilit:
- An episodic ataxia type‐1 mutation in the S1 segment sensitises the hKv1.1 potassium channel to extracellular Zn2+FEBS Letters, 2004
- Neurodegenerative diseases and oxidative stressNature Reviews Drug Discovery, 2004
- Iron inhibits neurotoxicity induced by trace copper and biological reductantsJBIC Journal of Biological Inorganic Chemistry, 2004
- Zinc and EpileptogenesisEpilepsy Currents, 2001
- CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2000
- Modulatory activity of extracellular H+ and Zn2+ on ATP‐responses at rP2X1 and rP2X3 receptorsBritish Journal of Pharmacology, 1999
- Zn2+ modulation of ATP‐responses at recombinant P2X2 receptors and its dependence on extracellular pHBritish Journal of Pharmacology, 1998
- GABA receptor-channel complex as a target site of Mercury, copper, zinc, and lanthanidesCellular and Molecular Neurobiology, 1994
- A heart-like Na+ current in the medial entorhinal cortexNeuron, 1993
- Nerve endings from rat brain tissue release copper upon depolarization. A possible role in regulating neuronal excitabilityNeuroscience Letters, 1989